NCT04956874

Brief Summary

The primary aim of this study is to test feasibility of a modified REACH II intervention in an outpatient clinic.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable alzheimer-disease

Timeline
Completed

Started Oct 2019

Shorter than P25 for not_applicable alzheimer-disease

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 4, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 17, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 17, 2020

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

June 22, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

July 9, 2021

Completed
Last Updated

April 10, 2024

Status Verified

April 1, 2024

Enrollment Period

12 months

First QC Date

June 22, 2021

Last Update Submit

April 9, 2024

Conditions

Keywords

CaregivingADRDMemory Disorders

Outcome Measures

Primary Outcomes (3)

  • Caregiver Burden

    Zarit Burden Inventory

    Baseline; 6 weeks (therapy termination); 6 month follow-up

  • Preparedness for Caregiving Measure

    Preparedness for dementia caregiving

    Baseline, session 2, 4, 6 (therapy termination); 6 month follow-up

  • Alzheimer's disease Knowledge Scale

    Knowledge of Alzheimers Disease and Related Dementias

    Baseline, 6 (therapy termination); 6 month follow-up

Secondary Outcomes (3)

  • Risk Assessment

    Baseline, 6 (therapy termination); 6 month follow-up

  • FL-REACH Satisfaction Survey

    Baseline, 6 (therapy termination); 6 month follow-up

  • Health Self-Report

    Baseline, 6 (therapy termination); 6 month follow-up

Study Arms (2)

Experimental Group

EXPERIMENTAL

Participants will complete the FL-REACH annualized caregiver intervention.

Behavioral: FL-REACH

Control Group

NO INTERVENTION

No-intervention control group

Interventions

FL-REACHBEHAVIORAL

The FL REACH intervention is a 6-session intervention designed to facilitate transition to care following delivery of a memory disorders diagnosis by a MDC team. The intervention focused on an approach that used a toolbox of strategies to tailor skills-based learning, knowledge transmission, and self-care strategies to dementia caregivers. This pilot study focuses on adapting the established REACH II intervention for translation to the clinical setting, with a focus not only on implementation of the key components of the program, but also on feasibility and sustainability. This is part of a stepped-care model that is being developed at the AdventHealth-Orlando MDC. Caregivers of patients will be referred to the FL REACH intervention for foundational training and skills-development.

Experimental Group

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Age 18-89 2. Identified caregiver or care partner of an individual who has been diagnosed with Alzheimer's disease or another dementia by the memory disorders clinic, and/or who has sought ongoing treatment through the memory disorders clinic 3. Able to provide informed consent 4. Able to engage in the intervention weekly by attending sessions in person at the clinic 5. Able to participate in the intervention in English or in Spanish 6. No previous experience with a caregiver training program in the past (this applies to theory based, structured interventions delivered by professionals, and does not include peer-led support groups that the family may have engaged with)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

AdventHealth

Orlando, Florida, 32803, United States

Location

University of Central Florida

Orlando, Florida, 32816, United States

Location

MeSH Terms

Conditions

Alzheimer DiseaseDementiaMemory Disorders

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Dementia caregivers were recruited initially. When dementia caregiver recruitment was completed, a small control group was recruited.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2021

First Posted

July 9, 2021

Study Start

October 4, 2019

Primary Completion

September 17, 2020

Study Completion

September 17, 2020

Last Updated

April 10, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

There is no plan to share IPD at this time.

Locations